Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Meta-analysis: Impact of drug class on adherence to antihypertensives
Ian M. Kronish
, Mark Woodward
, Ziad Sergie
, Gbenga Ogedegbe
, Louise Falzon
, Devin M. Mann
Research output
:
Contribution to journal
›
Article
›
peer-review
120
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Meta-analysis: Impact of drug class on adherence to antihypertensives'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Meta-analysis
100%
Hazard Ratio
100%
Drug Class
100%
Beta-blockers
66%
Angiotensin Receptor Blockers
66%
Diuretics
66%
95% Confidence Interval
66%
Angiotensin-converting Enzyme Inhibitor (ACEi)
50%
Odds Ratio
33%
Clinical Setting
33%
Low Adherence
33%
Antihypertensive Therapy
16%
Relative Risk
16%
Random Effects Model
16%
English Language
16%
Exclusion Criteria
16%
Publication Bias
16%
Antihypertensive Drug Class
16%
Calcium Channel Blockers
16%
Computerized Database
16%
High Adherence
16%
Medication Refill
16%
Drug Adherence
16%
Separate Class
16%
Refill Data
16%
Inverse Variance Weighted
16%
Medicine and Dentistry
Meta-Analysis
100%
Hazard Ratio
100%
Antihypertensive
100%
Angiotensin Receptor Antagonist
66%
Diuretics
66%
ACE Inhibitor
50%
Antihypertensive Agent
33%
Odds Ratio
33%
Observational Study
16%
Random Effects Model
16%
English (Language)
16%
Calcium Channel Blocking Agent
16%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin Receptor Antagonist
100%
Diuretics
100%
Antihypertensive
100%
Dipeptidyl Carboxypeptidase Inhibitor
75%
Antihypertensive Agent
50%
Observational Study
25%
Random Effects Model
25%
Calcium Channel Blocker
25%
Nursing and Health Professions
Meta Analysis
100%
Adherence
100%
Hazard Ratio
46%
Confidence Interval
30%
Angiotensin Receptor Antagonist
30%
Dipeptidyl Carboxypeptidase Inhibitor
23%
Odds Ratio
15%
Antihypertensive Agent
15%
Calcium Channel Blocking Agent
7%